About Eurofins Genomics
Eurofins Genomics is a company based in Bengaluru (India) founded in 1990.. Eurofins Genomics has completed 1 acquisition, including Blue Heron Bio. Eurofins Genomics offers products and services including Sanger Sequencing Service, Custom DNA Oligos, Gene Synthesis, and Next Generation Sequencing. Eurofins Genomics operates in a competitive market with competitors including Delphi Genetics, SwitchGear Genomics, DyNAbind, LIFE & BRAIN and SyngenTech, among others.
- Headquarter Bengaluru, India
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Eurofins Genomics Llc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$1.45 M (USD), Grant
Feb 17, 2024
- Investors
-
Employee Count
Employee Count
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Eurofins Genomics
Eurofins Genomics offers a comprehensive portfolio of products and services, including Sanger Sequencing Service, Custom DNA Oligos, Gene Synthesis, and Next Generation Sequencing. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides DNA sequencing with rapid results and quality checks.
Offers custom synthesized DNA for research and applications.
Enables creation of custom genes and fragments for experiments.
Delivers high-throughput sequencing for microbiome and genome studies.
Unlock access to complete
Funding Insights of Eurofins Genomics
- Total Funding Total Funding
- Total Rounds 3
- Last Round Grant — $1.5M
- First Round First Round
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2024 | Amount | Grant - Eurofins Genomics | Valuation |
investors |
|
| Nov, 2022 | Amount | Grant - Eurofins Genomics | Valuation |
investors |
|
| Dec, 2012 | Amount | Grant - Eurofins Genomics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Eurofins Genomics
Eurofins Genomics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Eurofins Genomics
Eurofins Genomics has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Blue Heron Bio. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Gene synthesis and sequencing services are provided using proprietary technology.
|
1999 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Eurofins Genomics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Eurofins Genomics Comparisons
Competitors of Eurofins Genomics
Eurofins Genomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Delphi Genetics, SwitchGear Genomics, DyNAbind, LIFE & BRAIN and SyngenTech, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of research services in molecular biology, protein engineering, and antibody development
|
|
| domain | founded_year | HQ Location |
Functional genomics tools and assays are developed for genome research.
|
|
| domain | founded_year | HQ Location |
DNA-Encoded Library technology is developed for drug discovery applications.
|
|
| domain | founded_year | HQ Location |
Biomedical and neuroscientific technologies are researched and developed.
|
|
| domain | founded_year | HQ Location |
Gene and cell therapeutics are developed via synthetic biology approaches.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Eurofins Genomics
Frequently Asked Questions about Eurofins Genomics
When was Eurofins Genomics founded?
Eurofins Genomics was founded in 1990 and raised its 1st funding round 22 years after it was founded.
Where is Eurofins Genomics located?
Eurofins Genomics is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Who is the current CEO of Eurofins Genomics?
Gilles Martin is the current CEO of Eurofins Genomics.
What does Eurofins Genomics do?
Eurofins Genomics was established in 1990 and operates from Bengaluru, India, within the genomics sector. Sequencing services and related products are offered to support research and applications in biotechnology. Operations focus on delivering reliable genomic solutions, with a presence indicated by the domain eurofinsgenomics.com. Leadership is provided by CEOs Gilles Martin and Michael Hadem, overseeing activities in this specialized field.
Who are the top competitors of Eurofins Genomics?
Eurofins Genomics's top competitors include Delphi Genetics, SwitchGear Genomics and DyNAbind.
What products or services does Eurofins Genomics offer?
Eurofins Genomics offers Sanger Sequencing Service, Custom DNA Oligos, Gene Synthesis, and Next Generation Sequencing.
How many acquisitions has Eurofins Genomics made?
Eurofins Genomics has made 1 acquisition, including Blue Heron Bio.
Who are Eurofins Genomics's investors?
Eurofins Genomics has 1 investor. Key investors include European Union.